Acetyl Hexapeptide-38 (Adifyline)_Dosage, benefits & legal status
Also known as Adifyline, Ac-SVVVRT-NH2
A topical sold on the idea that it grows fat cells.
Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.
What is Acetyl Hexapeptide-38 (Adifyline)?
Plain language first. The technical label stays, but it never stands alone.Overview
This one is sold on an unusual premise for a cream: that it makes the fat cells under your skin store more fat, so areas treated with it look fuller. There is no peer-reviewed human study of it at all. The volume figures come from the supplier's own brochure, and that document is worth looking at closely. It is marked edition 16B with a copyright of 2013 to 2016, carries no author, and its headline breast claim is a 30-fold improvement over placebo, a figure extraordinary enough that the absence of a published study behind it is the point. It is also not a lip ingredient, despite being widely described as one.
Acetyl hexapeptide-38 is a synthetic acetylated and amidated hexapeptide, Ac-Ser-Val-Val-Val-Arg-Thr-NH2, CAS 1400634-44-7, formula C30H56N10O9 and molecular weight 700.83. Lubrizol markets it as Adifyline, declared on the supplier brochure as Butylene Glycol, Water (Aqua), Acetyl Hexapeptide-38 at 0.05 percent active with a recommended 2 percent use level. The claimed mechanism is adipogenesis through PGC-1-alpha expression, with the brochure reporting a greater than 61 percent increase in PGC-1-alpha in vitro and higher lipid accumulation in treated cells. Its human data is supplier-generated: cheek volume up 12 percent after 14 days in 22 women aged 50 to 60, and a reported 30-fold breast volume improvement against placebo after 56 days in 22 women aged 25 to 40.
What it's used for
Cosmetic formulations marketed for facial fullness and body contouring. It has no medical use and no drug approval.
How does Acetyl Hexapeptide-38 (Adifyline) work?
What it does in the body, and where.Most cosmetic peptides claim to signal collagen or relax muscle. This one claims something different, and the claim is testable in principle and untested in practice.
- 01The premise: grow the fat, not the collagenFacial fullness and breast volume are largely a matter of subcutaneous fat. The supplier's proposal is that this peptide promotes adipogenesis, meaning it encourages fat cells to differentiate and to store lipid, and that doing so topically adds visible volume. The named pathway is PGC-1-alpha, a regulator of mitochondrial biogenesis and metabolism, with the brochure reporting an increase of more than 61 percent in PGC-1-alpha expression and greater lipid accumulation in treated cells.
- 02What the sequence isAc-Ser-Val-Val-Val-Arg-Thr-NH2: six residues with the N-terminus acetylated and the C-terminus amidated. We checked that against the published formula and mass rather than taking it on trust. The arithmetic for the acetylated, amidated hexapeptide gives C30H56N10O9 at 700.84 daltons, matching the published C30H56N10O9 and 700.83 exactly.
- 03The human data, and who produced itTwo supplier studies. Cheeks: 22 women aged 50 to 60 applied a 2 percent cream twice daily for 14 days, with volume measured by fringe projection, giving a reported 12 percent increase. Breast: 22 women aged 25 to 40 applied 2 percent cream to one breast and placebo to the other twice daily for 56 days, with the result reported as a 30-fold improvement over placebo. Neither has been published in a peer-reviewed journal, and the chart values behind the 30-fold figure were not legible in the brochure we read.
- 04Why a 30-fold claim deserves more scrutiny, not lessA 30-fold difference against placebo would be remarkable for any topical. A ratio that large usually means the placebo change was close to zero, in which case the ratio is arithmetically unstable and tells you little: dividing a small number by a smaller one produces a big multiple without a big effect. That is why the absolute values matter and why their absence is the problem.
- 05Four suppliers, four different mechanismsThe same INCI is described by Lubrizol as an adipogenesis promoter through PGC-1-alpha; by a second supplier in terms that garble PGC-1-alpha into stimulating peroxisome proliferators; by a reagent company as an anti-irritant that lowers IL-8 in keratinocytes, citing a skin-barrier patent; and by another as a dermal collagen stimulant whose sole citation is a review of natural collagen peptides not about this molecule at all. European ingredient databases list it simply as skin conditioning. Those are not variations on a theme; they are four unrelated claims about one six-residue peptide.
A schematic of the compound's mechanism, not a diagnostic image.
What else is it used for?
Each group carries its own evidence level.Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.
All the human data is supplier-generated
none- No dataCheek volume reported up 12 percent after 14 days in 22 women aged 50 to 60, using a 2 percent cream twice daily.
- No dataBreast volume reported as a 30-fold improvement over placebo after 56 days in 22 women, with the underlying absolute values not legible in the brochure.
- No dataNo peer-reviewed human study of this ingredient exists. Literature searches for acetyl hexapeptide-38 return papers about hexapeptide-8 instead.
Four suppliers, four incompatible mechanisms
none- No dataLubrizol: adipogenesis via PGC-1-alpha, for cheek and breast volume. A second supplier repeats this while garbling PGC-1-alpha into stimulating peroxisome proliferators.
- No dataA reagent company describes the same molecule as an anti-irritant that lowers IL-8 in keratinocytes.
- No dataAnother describes it as a dermal collagen stimulant, citing a review of natural collagen peptides that is not about this molecule.
- lab-analysisEuropean cosmetic ingredient databases list only skin conditioning.
Identity, checked rather than taken on trust
none- lab-analysisAc-Ser-Val-Val-Val-Arg-Thr-NH2. Calculating the formula for that acetylated, amidated hexapeptide gives C30H56N10O9 at 700.84 daltons, matching the published C30H56N10O9 and 700.83.
- No dataThe site's existing acetyl hexapeptide-37 page covers Ac-SPAGGP-NH2, sold for hydration. Adjacent numbers, unrelated molecules, and at least one finished lip product contains both.
The lip claim is the clearest error. This ingredient is widely described as a lip plumper, and no supplier document we found mentions lips at all: the only human testing described is on cheeks and breast. The association appears to come from a popular lip product in which this peptide sits twentieth of forty-six ingredients, below fragrance, and where the brand itself credits the plumping sensation to a warming vasodilator and a hyaluronic acid complex rather than to this peptide. Second, the 30-fold breast figure should not be repeated as though it were an effect size: a ratio that large against a near-zero placebo change is arithmetically unstable, and the absolute numbers behind it are not legible in the brochure. Third, the ingredient is confused with acetyl hexapeptide-37, a different molecule sold for hydration whose page is already on this site. Fourth, the mechanism it is given depends entirely on which supplier you read, and literature searches for it mostly return studies of hexapeptide-8.
The published record
Papers and trials about Acetyl Hexapeptide-38 (Adifyline)
Searched: acetyl hexapeptide-38, Adifyline.
Left out: hexapeptide-8 (OBSERVED contamination, not hypothetical: every Crossref hit for acetyl hexapeptide-38 turned out to be about hexapeptide-8 instead. This is the single most important rejection on this row); acetyl hexapeptide-37 (Diffuporine, Ac-SPAGGP-NH2, a different molecule sold for hydration that already has its own slug; the adjacent number invites confusion and at least one finished lip product contains both); PGC-1alpha (a metabolism regulator with a very large unrelated literature); adipogenesis (a large cell-biology literature unrelated to this molecule); argireline (acetyl hexapeptide-3, yet another numeric sibling with its own slug).
Furthest stage reached: No clinical trial on record
Counted from Europe PMC indexing, not read by a person; a human tag can land on reviews, commentary or lab papers; clinical trial publications is the narrower count.

At a glance
Four things to know about Acetyl Hexapeptide-38 (Adifyline)
Evidence
Cosmetic
Category
Skin and cosmetic
Common vial
Varies
Half-life
Not applicable
How much, and do you cycle it?
The range, and whether you take breaks.Set by the finished product, as directed by the product. Not applicable No range
An ingredient in a finished cosmetic, used as the product directs. No cycling scheme applies.
Not applicableNo figure
No half-life has been published, and a circulating half-life would not be the useful measure for a topical cosmetic ingredient.
You can compare this against the whole library to see where it sits.
How is it given?
Dosing context and source notes.Supplied as a ready-made solution, so there is nothing to mix.
How do you store it?
Before mixing, and after.Room temperature, out of light. Cap it tight after each use.
Acetyl Hexapeptide-38 (Adifyline) ships as a cream, gel, or serum. Keep it at room temperature away from sun and heat unless the label says otherwise. Refrigerating an emulsion can split the texture. Watch for color, smell, or separation changes and stop using it if any appear.
What are the side effects and cautions?
Known cautions and warnings for this compound.Solubility, computed: 50% charged residues, 50% hydrophobic. Water usually sufficient.
A first-pass rule from peptide manufacturers' guidance. It does not account for disulfide bridges, salt form or how the powder was dried, and it predicts what should be easy rather than what will happen in your vial.
Who should avoid it
- Any expectation of volume change: no peer-reviewed human study of this ingredient exists, and the volume figures are supplier-generated
- Buying it for lips: no supplier document we found mentions lips, and the only human testing described is on cheeks and breast
Stop and get help
- Signs of an allergic skin reaction, such as spreading redness, swelling or blistering
Common effects
- Nothing established in a published human study
Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.
Is Acetyl Hexapeptide-38 (Adifyline) approved?
And where the numbers on this page come from.Not as a medicine. Acetyl Hexapeptide-38 (Adifyline) is sold without a prescription as a cosmetic ingredient, which is a different thing from being approved as a drug.
- Approval statusCosmeticSold without a prescription as an ingredient in cosmetics, such as skincare and hair products. The FDA does not approve cosmetics before they are sold, and being easy to buy says nothing about whether it works.
- RouteOn the skin (cream or serum)
- Checked30 October 2026
- DoseNo dose has been established in people.
- Vial sizeFrom what vendors typically list; not a recommendation.
- Sources
What has happened recently
A cosmetic ingredient, not a drug, requiring no premarket approval for safety or for claim accuracy. The INCI name is ACETYL HEXAPEPTIDE-38 and the CAS number is 1400634-44-7. Two documentation problems are worth recording. First, the principal supplier brochure is undated in any meaningful sense: it carries the edition code 16B and a copyright of 2013 to 2016, names no author, and lists Lipotec in Gava, Barcelona as the contact, while the trademark belongs to Lubrizol. It is a decade-old marketing document still being served. Second, the sold composition is declared as Butylene Glycol, Water (Aqua), Acetyl Hexapeptide-38, with the carrier listed first and the active at 0.05 percent, so the ingredient a reader thinks they are buying is a small fraction of the material. Note also the numeric-sibling trap: this site already has a page for acetyl hexapeptide-37, namely Ac-SPAGGP-NH2, sold for hydration. The two are unrelated molecules with adjacent numbers, and at least one finished lip product contains both.
You can compare this against the whole library, or read how to check a seller.
What else is like Acetyl Hexapeptide-38 (Adifyline)?
Others in Skin and cosmetic, side by side.If you're weighing Acetyl Hexapeptide-38 (Adifyline), it's worth reading Acetyl Tetrapeptide-11, Acetyl Tetrapeptide-15 (Skinasensyl), and Acetyl Tetrapeptide-2 (Thymulen 4) in the same class.
A topical sold on the idea that it grows fat cells.
- Dose
- Set by the finished product
- How often
- As directed by the product
A topical cosmetic peptide sold as Syniorage, claimed to firm mature skin by raising syndecan-1 and collagen XVII.
- Dose
- Serum or cream, per product
- How often
- Daily
An acetyl-capped copy of endomorphin-2, an opioid peptide, sold by BASF as Skinasensyl to make reactive skin less easily irritated. Its only data are supplier tests published without numbers.
- Dose
- BASF use level not public; 0.0015% in the supplier's volunteer test (2021 review)
- How often
- Twice daily (supplier test)
A four-residue piece of the thymus hormone thymopoietin, close kin to thymopentin, sold by two suppliers with two different stories. Its only independent study was done in cultured skin cells.
- Dose
- 2% Uplevity solution in a cream or serum (supplier), about 10 ppm peptide if the solution is 0.05% peptide
- How often
- Twice daily (supplier test)
Guides for this compound
- mcg vs mg: The Peptide Dosing Mistake to Avoid
Your vial says mg and your protocol says mcg. Here is the conversion and how to check it.
- How to Read a Peptide COA
What the purity number does and does not tell you, and how to spot an edited report.
- How to Vet a Peptide Vendor
Independent COAs, HPLC purity, and the red flags that mean walk away.
Sources
- Lubrizol Adifyline peptide brochure(2016)The supplier's own document and the origin of every number on this page. Declares the composition verbatim as Butylene Glycol, Water (Aqua), Acetyl Hexapeptide-38, with 0.05 percent acetyl hexapeptide-38 and a recommended dosage of 2 percent. In vitro: the peptide promoted PGC-1-alpha expression by more than 61 percent, and lipid accumulation is higher in treated cells. In vivo on cheeks: 22 female volunteers aged 50 to 60, 2 percent cream twice daily for 14 days, volume by fringe projection, cheek volume increased by 12 percent. In vivo on breast: 22 women aged 25 to 40 with bra cup 80 to 90, 2 percent cream on one breast and placebo on the other, twice daily for 56 days, volume by FOITS at days 14, 28 and 56, reported as a 30-fold improvement against placebo; the underlying chart values were not legible in the copy we read. The document gives no sequence and no CAS. It carries the edition code Ed. 16B, a copyright of 2013 to 2016, and no named author, listing Lipotec in Gava, Barcelona as contact. The document does not mention lips anywhere.
Beyond these, 1 records are indexed. Browse the records
